CompletedNot Applicable

Human Papillomatosis Genotyping of Children in Thailand

Thailand15 participantsStarted 2011-03

Plain-language summary

The purpose of the present study was to identify risk factors for more severe juvenile Recurrent Respiratory Papillomatosis (RRP) through prospective evaluation of a pediatric population in Thailand by the employing a protocol that includes staging of disease severity using above mentioned staging system at the time of each endoscopic debridement, as well as human papilloma virus (HPV) genotyping.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients have active laryngeal papillomatosis . * Patients have developed this infection before the age of 18 years old. Exclusion Criteria: * Children whose families do not sign an informed consent to enter into study. * Children whose families anticipate discontinuing care at a participating institution during the study period.

What they're measuring

Human Papillomavirus Genotypes

Timeframe: 12 months

Trial details

NCT IDNCT01304966

SponsorQueen Sirikit National Institute of Child Health

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2012-09

Results submitted2013-04-13

View on ClinicalTrials.gov More Recurrent Laryngeal Papillomatosis trials